Efficacy and safety of a protocol-based treatment of severe early diffuse systemic sclerosis (dSSc) using mycophenolate mofetil (MMF) in combination with intravenous methylprednisolone (IV MP) pulses.

Vanthuyne, Marie; Houssiau, Frédéric; Blockmans, Daniel; Westhovens, Rene; Roufosse, Florence; Cogan, Elie; Depresseux, Geneviève

Efficacy and safety of a protocol-based treatment of severe early diffuse systemic sclerosis (dSSc) using mycophenolate mofetil (MMF) in combination with intravenous methylprednisolone (IV MP) pulses.

Vanthuyne, Marie

;

Houssiau, Frédéric

;

Blockmans, Daniel

;

Westhovens, Rene

;

Depresseux, Geneviève

;et.al.

(2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: Washington (Dc) (10.November.2006)

Files

No attached file found for this publication.

Details

Authors

Vanthuyne, MarieUCLouvain
Author
Houssiau, FrédéricUCLouvain
Author
Blockmans, Daniel
Author
Westhovens, Rene
Author
Depresseux, GenevièveUCLouvain
Author

Affiliations

Citations

APA
Chicago
FWB

Vanthuyne, M., Houssiau, F., Blockmans, D., Westhovens, R., Roufosse, F., Cogan, E., & Depresseux, G. (2006). Efficacy and safety of a protocol-based treatment of severe early diffuse systemic sclerosis (dSSc) using mycophenolate mofetil (MMF) in combination with intravenous methylprednisolone (IV MP) pulses. Arthritis & Rheumatism, 54(9), S480-S480. https://hdl.handle.net/2078.5/139556 (Original work published 2006)